Blue Fin Capital Inc. Sells 73 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Blue Fin Capital Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 16,319 shares of the healthcare conglomerate’s stock after selling 73 shares during the quarter. UnitedHealth Group comprises about 1.5% of Blue Fin Capital Inc.’s portfolio, making the stock its 14th largest position. Blue Fin Capital Inc.’s holdings in UnitedHealth Group were worth $8,255,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group in the fourth quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $30,000. Finally, AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $30,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other news, Director John H. Noseworthy bought 300 shares of the firm’s stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the purchase, the director now directly owns 6,063 shares in the company, valued at $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the business’s stock in a transaction on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock worth $31,607,768 over the last three months. 0.33% of the stock is owned by insiders.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. KeyCorp dropped their price objective on shares of UnitedHealth Group from $575.00 to $450.00 and set an “overweight” rating on the stock in a report on Wednesday, May 14th. TD Securities reiterated a “hold” rating and issued a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday. TD Cowen lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a research report on Monday. Finally, Mizuho lowered their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a report on Friday, May 16th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $441.87.

UnitedHealth Group Trading Down 5.8%

Shares of UNH stock opened at $303.08 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a 50 day moving average of $460.62 and a 200-day moving average of $508.74. The firm has a market cap of $274.93 billion, a P/E ratio of 19.55, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the company earned $6.91 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 2.77%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.